Hypoxia and Renal Tubulointerstitial Fibrosis

被引:24
|
作者
Li, Zuo-Lin [1 ]
Liu, Bi-Cheng [1 ]
机构
[1] Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China
来源
关键词
Hypoxia; Tubulointerstitial fibrosis; Hypoxia-inducible factor; ACUTE KIDNEY INJURY; ENDOTHELIAL-MESENCHYMAL TRANSITION; HIF-PROLYL HYDROXYLASES; OXYGEN-TENSION; INDUCIBLE FACTOR-1-ALPHA; CARDIOPULMONARY BYPASS; PROMOTES FIBROGENESIS; THERAPEUTIC TARGETS; NITRIC-OXIDE; EXPRESSION;
D O I
10.1007/978-981-13-8871-2_23
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hypoxia, one of the most common causes of kidney injury, is a key pathological condition in various kidney diseases. Renal fibrosis is the terminal pathway involved in the continuous progression of chronic kidney disease (CKD), characterized by glomerulosclerosis and tubulointerstitial fibrosis (TIF). Recent studies have shown that hypoxia is a key factor promoting the progression of TIF. Loss of microvasculature, reduced oxygen dispersion, and metabolic abnormality of cells in the kidney are the main causes of the hypoxic state. Hypoxia can, in turn, profoundly affect the tubular epithelial cells, endothelial cells, pericytes, fibroblasts, inflammatory cells, and progenitor cells. In this chapter, we reviewed the critical roles of hypoxia in the pathophysiology of TIF and discussed the potential of anti-hypoxia as its promising therapeutic target.
引用
收藏
页码:467 / 485
页数:19
相关论文
共 50 条
  • [1] The renal cortical fibroblast in renal tubulointerstitial fibrosis
    Qi, WE
    Chen, XM
    Poronnik, P
    Pollock, CA
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (01): : 1 - 5
  • [2] Polycystins Are Required for Renal Tubulointerstitial Fibrosis
    Wang, Yanzhe
    Wu, Ming
    Ye, Chaoyang
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 403 - 403
  • [3] POLYCYSTINS ARE REQUIRED FOR RENAL TUBULOINTERSTITIAL FIBROSIS
    Xing, Yufeng
    Wu, Ming
    Ye, Chaoyang
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I413 - I413
  • [4] Effect of pirfenidone on renal tubulointerstitial fibrosis
    Li D.
    Zeng H.
    Ji C.
    [J]. Frontiers of Medicine in China, 2009, 3 (3): : 316 - 322
  • [5] Hypoxia and renal fibrosis
    Naas, Stephanie
    Schiffer, Mario
    Schoedel, Johannes
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2023, 325 (04): : C999 - C1016
  • [6] Mechanisms of norcantharidin against renal tubulointerstitial fibrosis
    Qin-Su Yun
    Yu-Xin Bao
    Jie-Bing Jiang
    Qian Guo
    [J]. Pharmacological Reports, 2024, 76 : 263 - 272
  • [7] Mechanisms of norcantharidin against renal tubulointerstitial fibrosis
    Yun, Qin-Su
    Bao, Yu-Xin
    Jiang, Jie-Bing
    Guo, Qian
    [J]. PHARMACOLOGICAL REPORTS, 2024, 76 (02) : 263 - 272
  • [8] Renal tubulointerstitial fibrosis: common but never simple
    Hewitson, Tim D.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 296 (06) : F1239 - F1244
  • [9] Renal tubulointerstitial hypoxia: Cause and consequence of kidney dysfunction
    Palm, Fredrik
    Nordquist, Lina
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (07): : 424 - 430
  • [10] Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring
    Hewitson, TD
    Darby, IA
    Bisucci, T
    Jones, CL
    Becker, GJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1998, 9 (04): : 632 - 642